Except where otherwise noted, this work is distributed under the terms of a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International licence (CC BY-NC-ND), a copy of which is available at http://creativecommons.org/licenses/by-nc-nd/4.0/
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Glycerol Phenylbutyrate (Ravicti) [Internet]. Ottawa (ON): Canadian Agency for Drugs and Technologies in Health; 2017 Apr.
- INFORMATION ON THE PHARMACOECONOMIC SUBMISSION - Glycerol Phenylbutyrate (Ravict...INFORMATION ON THE PHARMACOECONOMIC SUBMISSION - Glycerol Phenylbutyrate (Ravicti)
- Description and Appraisal of Outcome Measures - Clinical Review Report: Icosapen...Description and Appraisal of Outcome Measures - Clinical Review Report: Icosapent Ethyl (Vascepa)
- Additional Cost Comparators - Pharmacoeconomic Review Report: tiotropium bromide...Additional Cost Comparators - Pharmacoeconomic Review Report: tiotropium bromide monohydrate (Spiriva Respimat) for inhalation
- Summary of Other Studies - Clinical Review Report: Slexipag (Uptravi)Summary of Other Studies - Clinical Review Report: Slexipag (Uptravi)
- Literature Search Strategy - Clinical Review Report: Cysteamine delayed-release ...Literature Search Strategy - Clinical Review Report: Cysteamine delayed-release capsules (Procysbi)
Your browsing activity is empty.
Activity recording is turned off.
See more...